TREACE MEDICAL CONCEPTS INC
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits, Financial Statement Schedules
(a)
The following documents are filed as part of this Annual Report:
(1)
FINANCIAL STATEMENTS
Our financial statements are listed in the "Index to the Financial Statements" under Part II, Item 8, "Financial Statements and Supplementary Data" of this Annual Report.
(2)
FINANCIAL STATEMENT SCHEDULES
Schedule II. Valuation and Qualifying Accounts (in thousands):
| Additions | |||||
|---|---|---|---|---|---|
| Balance at beginning of period | Charged to expenses | Charged to other accounts | Write-offs and deductions, net of recoveries | Balance at end of period | |
| Allowance for credit losses: | |||||
| Year ended December 31, 2024 | $980 | $2,947 | $— | $(2,601) | $1,326 |
| Year ended December 31, 2023 | 735 | 434 | — | (189) | 980 |
| Year ended December 31, 2022 | 414 | 411 | — | (90) | 735 |
| Deferred tax asset valuation allowance: | |||||
| Year ended December 31, 2024 | $35,211 | $8,935 | $— | $— | $44,146 |
| Year ended December 31, 2023 | 22,864 | 12,347 | — | — | 35,211 |
| Year ended December 31, 2022 | 11,941 | 10,923 | — | — | 22,864 |
(3)
EXHIBITS
The documents listed in the Exhibit Index of this Annual Report are incorporated by reference or are filed with this Annual Report, in each case as indicated therein.
EXHIBIT INDEX
Incorporated by Reference
| Exhibit Number · Description · Form · File No. · Exhibit · Filing Date · Filed Herewith | |||||
|---|---|---|---|---|---|
| 3.1 | Amended and Restated Certificate of Incorporation of Treace Medical Concepts, Inc. | 8-K | 001-40355 | 3.1 | 4-27-21 |
| 3.2 | Amended and Restated Bylaws of Treace Medical Concepts, Inc. | 8-K | 001-40355 | 3.2 | 4-27-21 |
| 4.1 | Form of Common Stock Certificate | S-1/A | 333-254863 | 4.2 | 4-19-21 |
| 4.2 | Description of common stock of Treace Medical Concepts, Inc. | 10-K | 001-40355 | 4.2 | 3-4-22 |
| 10.1+ | Change in Control Severance Agreement by and between Treace Medical Concepts, Inc. and John T. Treace | S-1/A | 333-254863 | 10.13 | 4-19-21 |
| 10.2+ | Change in Control Severance Agreement by and between Treace Medical Concepts, Inc. and Mark L. Hair | S-1/A | 333-254863 | 10.6 | 4-19-21 |
| 10.3+ | Change in Control Severance Agreement by and between Treace Medical Concepts, Inc. and Aaron Berutti | 10-Q | 001-40355 | 10.2 | 11-4-21 |
| 10.4+ | Change in Control Severance Agreement by and between Treace Medical Concepts, Inc. and Scot M. Elder | 10-K | 001-40355 | 10.7 | 3-4-22 |
| 10.5+ | Change in Control Severance Agreement by and between Treace Medical Concepts, Inc. and Sean F. Scanlan | 10-Q | 001-40355 | 10.7 | 8-5-21 | |
| 10.6+ | Change in Control Severance Agreement by and between Treace Medical Concepts, Inc. and Gaetano Guglielmino | X | ||||
| 10.7+ | Form of Indemnification Agreement for directors and executive officers | S-1/A | 333-254863 | 10.1 | 4-19-21 | |
| 10.8+ | 2014 Stock Plan, as amended | S-1 | 333-254863 | 10.2(a) | 3-30-21 | |
| 10.9+ | Form of Stock Option Agreement for Directors under 2014 Stock Plan | S-1 | 333-254863 | 10.2(b) | 3-30-21 | |
| 10.10+ | Form of Stock Option Agreement for Employees under 2014 Stock Plan | S-1 | 333-254863 | 10.2(c) | 3-30-21 | |
| 10.11+ | Form of Notice of Option Exercise under 2014 Stock Plan | S-1 | 333-254863 | 10.2(d) | 3-30-21 | |
| 10.12+ | 2021 Incentive Award Plan and related form agreements | S-1/A | 333-254863 | 10.3 | 4-19-21 | |
| 10.13+ | Form of Performance Stock Unit Award For Employees under 2021 Incentive Award Plan | 10-Q | 001-40355 | 10.1 | 11-9-23 | |
| 10.14+ | 2021 Employee Stock Purchase Plan | S-1/A | 333-254863 | 10.11 | 4-19-21 | |
| 10.15+ | Non-Employee Director Compensation Program | X | ||||
| 10.16 | Form of Product Development Royalty Agreement | S-1 | 333-254863 | 10.12 | 3-30-21 | |
| 10.17 | Credit and Security Agreement (Revolving Loan) dated as of April 29, 2022, by and among Treace Medical Concepts, Inc. and Midcap Funding IV Trust | 10-Q | 001-40355 | 10.1 | 8-10-22 | |
| 10.18 | Credit and Security Agreement (Term Loan) dated as of April 29, 2022 by and among Treace Medical Concepts, Inc. and Midcap Financial Trust | 10-Q | 001-40355 | 10.2 | 8-10-22 | |
| 10.19 | Amendment to Credit and Security Agreement (Revolving Loan) dated as of April 29, 2022, by and among Treace Medical Concepts, Inc. and Midcap Funding IV Trust | 10-Q | 001-40355 | 10.1 | 11-9-22 | |
| 10.20 | Amendment to Credit and Security Agreement (Term Loan) dated as of April 29, 2022 by and among Treace Medical Concepts, Inc. and Midcap Financial Trust | 10-Q | 001-40355 | 10.2 | 11-9-22 | |
| 19.1 | Insider Trading Compliance Policy | X | ||||
| 23.1 | Consent of Grant Thornton LLP, Independent Registered Public Accounting Firm | X | ||||
| 31.1 | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 31.2 | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 32.1# | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as | X | ||||
| 32.2# · Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 · X | |||||
|---|---|---|---|---|---|
| 97.1 | Policy For Recovery of Erroneously Awarded Compensation | 10-K | 001-40355 | 97.1 | 2-27-25 |
| 101.INS | Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document. | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents | ||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | ||||
- Indicates management contract or compensatory plan.
The certifications attached as Exhibit 32.1 and 32.2 that accompany this Annual Report are deemed furnished and not filed with the U.S. Securities and Exchange Commission and are not to be incorporated by reference into any filing of Treace Medical Concepts, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Annual Report, irrespective of any general incorporation language contained in such filing.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.